Patents Assigned to APHARM S.R.L.
  • Combination of glycosaminoglycans and an antacid agent and compositions thereof
    Patent number: 11116786
    Abstract: The present invention refers to a combination of hyaluronic acid, chondroitin sulfate in combination with at least one antacid agent, in particular magaldrate, for the prevention or treatment of gastric hyperacidity and gastroesophageal reflux and related pathologies thereof. More particularly, the combination is used for the preparation of oral compositions with at least one pharmaceutical carrier and advantageously that comprise a bioadhesive agent as well.
    Type: Grant
    Filed: September 30, 2016
    Date of Patent: September 14, 2021
    Assignee: APHARM S.R.L.
    Inventors: Angelo Pizzoni, Paolo Pizzoni
  • Combination of hyaluronic acid and macrogol and pharmaceutical compositions containing it
    Patent number: 10471092
    Abstract: The invention relates to a new combination of hyaluronic acid and macrogol, pharmaceutical compositions containing said combination and the use of the combination and compositions as laxatives.
    Type: Grant
    Filed: November 3, 2015
    Date of Patent: November 12, 2019
    Assignee: APHARM S.r.l.
    Inventor: Angelo Pizzoni
  • Combination of glycosaminoglycans and cyclodextrins
    Patent number: 9974803
    Abstract: The invention relates to an injectable combination of two specific glycosaminoglycans, hyaluronic acid and chondroitin sulfate, with cyclodextrins and the use of the combination for the treatment of diseases related to the skeletal systems, particularly in the intra-articular treatment, as well as in the intradermal treatment.
    Type: Grant
    Filed: December 15, 2014
    Date of Patent: May 22, 2018
    Assignee: APHARM S.R.L.
    Inventors: Angelo Pizzoni, Paolo Pizzoni
  • Glycosaminoglycan oral use and compositions
    Patent number: 9241953
    Abstract: The present invention concerns the use of a glycosaminoglycan association of hyaluronic acid and chondroitin sulfate for the preparation of oral compositions for the prevention or for the treatment of upper gastro-intestinal tract disorders and for the preparation of upper gastro-intestinal epithelial damage, as well as the oral compositions comprising said glycosaminoglycan association.
    Type: Grant
    Filed: December 20, 2013
    Date of Patent: January 26, 2016
    Assignee: APHARM S.R.L.
    Inventor: Angelo Pizzoni
  • Glycosaminoglycan oral use and compositions
    Patent number: 8735373
    Abstract: The present invention concerns the use of a glycosaminoglycan association of hyaluronic acid and chondroitin sulfate for the preparation of oral compositions for the prevention or for the treatment of upper gastro-intestinal tract disorders and for the preparation of upper gastro-intestinal epithelial damage, as well as the oral compositions comprising said glycosaminoglycan association.
    Type: Grant
    Filed: May 8, 2009
    Date of Patent: May 27, 2014
    Assignee: Apharm S.R.L.
    Inventor: Angelo Pizzoni
  • GLYCOSAMINOGLYCAN ORAL USE AND COMPOSITIONS
    Publication number: 20140107064
    Abstract: The present invention concerns the use of a glycosaminoglycan association of hyaluronic acid and chondroitin sulfate for the preparation of oral compositions for the prevention or for the treatment of upper gastro-intestinal tract disorders and for the preparation of upper gastro-intestinal epithelial damage, as well as the oral compositions comprising said glycosaminoglycan association.
    Type: Application
    Filed: December 20, 2013
    Publication date: April 17, 2014
    Applicant: APHARM S.R.L.
    Inventor: Angelo PIZZONI